Gimeno V, Castellsague J, Varas-Lorenzo C, Hopkins JS, Eaton SC, Perez-Gutthann S. Gastrointestinal and cardiovascular characterization of users of COX-2 specific inhibitors. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):43.
Nadjar A, Martin AR, Giroudet C, Lewis S, Conway K, Lindley C, Olver I. Multi-national phase III trials of aprepitant for the prevention of cinv: translation and linguistic validation of an emesis diary and patient questionnaire into 22 languages. Presented at the 2003 American Society of Clinical Oncology Annual Meeting, Abstract No. 3158; January 1, 2003. Chicago, IL.